Adipokines and metabolic syndrome risk factors in women with previous gestational diabetes mellitus

Diabetes/Metabolism Research and Reviews

Volumn 28, Issue 6, 2012, Pages 542-548

  Roca Rodríguez, M Mar ^a   López Tinoco, Cristina ^b   Fernández Deudero, Álvaro ^b   Murri, Mora ^a   García Palacios, María Victoria ^b   García Valero, M Amor ^b   Tinahones Madueño, Francisco J ^a   Aguilar Diosdado, Manuel ^b  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

^b HOSPITAL UNIVERSITARIO PUERTA DEL MAR   (Spain)

Author keywords

Adipokines; Gestational diabetes mellitus; Metabolic syndrome; Postpartum

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; INSULIN; INTERLEUKIN 6; LEPTIN; TUMOR NECROSIS FACTOR ALPHA; URIC ACID;

ARTICLE; BODY MASS; CARBOHYDRATE METABOLISM; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; LIPID METABOLISM; METABOLIC SYNDROME X; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PREGNANCY DIABETES MELLITUS; PREVALENCE; PRIORITY JOURNAL; PUERPERIUM; RISK FACTOR; WAIST CIRCUMFERENCE;

ADIPOKINES; ADIPONECTIN; ADULT; BLOOD GLUCOSE; BODY MASS INDEX; CARDIOVASCULAR DISEASES; DIABETES, GESTATIONAL; FASTING; FEMALE; HUMANS; INSULIN; LEPTIN; LIPIDS; METABOLIC SYNDROME X; POSTPARTUM PERIOD; PREGNANCY; PREVALENCE; RISK FACTORS;

EID: 84865736485     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.2313     Document Type: Article

References (37)

1. Pallardo F, Herranz L, García Ingelmo T, et al. Early postpartum metabolic assessment in women with prior gestational diabetes. Diabetes Care 1999; 22: 1053-1058.
2. Retnakaran R, Qi Y, Sermer M, Connelly PW, Hanley AJ, Zinman B. Glucose intolerance in pregnancy and future risk of prediabetes or diabetes. Diabetes Care 2008; 31(10): 2026-2031.
3. Albareda M, Caballero A, Badell G, et al. Diabetes and abnormal glucose tolerance in women with previous gestational diabetes. Diabetes Care 2003; 26: 1199-1205.
4. Sattar N, Greer I. Pregnancy complications and maternal cardiovascular risk: opportunities for intervention and screening? BMJ 2002; 325: 157-160.
5. Festa A, D'Agostino R Jr, Howard G, Mykkanen L, Tracy RP, Haffner SM. Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 2000; 102: 42-47.
6. Reaven G. The insulin resistance syndrome. Curr Atheroscler Rep 2003; 5: 364-371.
7. Grundy SM, Cleeman J, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Curr Opin Cardiol 2006; 21: 1-6.
8. Maeda K, Okubo K, Shimomura I, Mizuno K, Matsuzawa Y, Matsubara K. Analysis of an expression profile of genes in the human adipose tissue. Gene 1997; 190: 227-235.
9. Funahashi T, Nakamura T, Shimomura I, et al. Role of adipocytokines on the pathogenesis of atherosclerosis in visceral obesity. Int Med 1999; 38: 202-206.
10. Adami GF, Ravera G. Metabolic syndrome in severely obese patients. Obes Surg 2001; 11: 543-545.
11. Frayn KN. Adipose tissue and the insulin resistance syndrome. Proc Nutr Soc 2001; 60: 375-380.
12. Hotamisligil GS, Shargill N, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity linked insulin resistance. Science 1993; 259: 87-91.
13. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 1994; 372: 425-432.
14. Haslam DW, James W. Obesity. Lancet 2005; 366: 1197-11209.
15. Mohamed-Ali V, Goodrick S, Rawesh A, et al. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-α, in vivo. J Clin Endocrinol Metab 1997; 82: 4196-4200.
16. Bastard JP, Maachi M, Van Nhieu JT, et al. Adipose tissue IL-6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitro. J Clin Endocrinol Metab 2000; 87: 2084-2089.
17. Muller S, Martin S, Koenig W, et al. Impaired glucose tolerance is associated with increased serum concentrations of interleukin 6 and coregulated acute-phase proteins but not TNF-α or its receptors. Diabetologia 2000; 45: 805-812.
18. Ziccardi P, Nappo F, Giugliano G, et al. Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after with loss over one year. Circulation 2002; 105: 804-809.
19. Pellme F, Smith U, Funahashi T, et al. Circulating adiponectin level are reduced in nonobese but insulin-resistant first degree relatives of type 2 diabetes patients. Diabetes 2003; 52: 1182-1186.
20. Atègbo JM, Grissa O, Yessoufou A, et al. Modulation of adipokines and cytokines in gestational diabetes and macrosomia. J Clin Endocrinol Metab 2006; 91(10): 4137-4143.
21. Moritmisu LK, Fusaro A, Sanchez VH, Hagemann CCF, Bertini AM, Dib SA. Fibrinolytic dysfunction after gestation is associated to components of insulin resistance and early type 2 diabetes in Latino women with previous gestational diabetes. Diab Res Clin Prac 2007; 78: 340-348.
22. Catalano PM, Huston L, Amini SB, Kalhan SC. Longitudinal changes in glucose metabolism during pregnancy in obese women with normal glucose tolerance and gestational diabetes. Am J Obstet Gynecol 1999; 180: 903-916.
23. Lopez-Tinoco C, Roca M, Fernández-Deudero A, et al. Cytokine profile, metabolic syndrome and cardiovascular disease risk in women with late-onset gestational diabetes mellitus. Cytokine 2012; 58: 14-19.
24. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979; 28: 1039-1057.
25. Heitritter S, Solomon C, Mitchel G, Skali-Ounis N, Seely E. Subclinical inflammation and vascular dysfunction in women with previous gestational diabetes mellitus. J Clin Endocrinol Metab 2005; 90(7): 3983-3988.
26. Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factor associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004; 364: 937-951.
27. Yusuf S, Hawken S, Ounpuu S, et al. Obesity and the risk of myocardial infarction in 27, 000 participants from 52 countries: a case-control study. Lancet 2005; 366: 1640-1649.
28. Meyers-Seifer CH, Vohr B. Lipid levels in former gestational diabetic mothers. Diabetes Care 1996; 19: 1351-1356.
29. Retnakaran R, Qi Y, Connelly PW, Sermer M, Hanley AJ, Zinman B. Risk of Early Progression to Pre-diabetes or Diabetes in Women with Recent Gestational Dysglycemia but Normal Glucose Tolerance at 3-months Postpartum. Clin Endocrinol 2010; 73: 476-483.
30. Solomon CG, Willett W, Carey VJ, et al. A prospective study of pregravid determinants of gestational diabetes mellitus. JAMA 1997; 278: 1078-1083.
31. Cardona F, Rojo-Martinez G, Almaraz MC, Soriguer F, Garcia-Fuentes E, Tinahones FJ. El ácido úrico es un predictor de desarrollo de diabetes mellitus tipo 2 en la población general. Endocrinol Nutr 2009; 56(2): 66-70.
32. Basi S, Lewis J. Microalbuminuria as a target to improve cardiovascular and renal outcomes. Am J Kidney Dis 2006; 47: 927-946.
33. Kautzky-Willer A, Pacini G, Tura A, et al. Increased plasma leptin in gestational diabetes. Diabetologia 2001; 44: 164-172.
34. Simmons D, Breier B. Fetal overnutrition in Polynesian pregnancies and in gestational diabetes may lead to dysregulation of the adipoinsular axis in offspring. Diabetes Care 2002; 25(9): 1539-1544.
35. Bays H, Mandarino L, DeFronzo RA. Role of the adipocyte, free fatty acids, and ectopic fat in pathogenesis of type 2 diabetes mellitus: peroxisomal proliferator-activated receptor agonists provide a rational therapeutic approach. J Clin Endocrinol Metab 2004; 89: 463-478.
36. Costacou T, Bosnyak Z, Harger GF, Markovic N, Silvers N, Orchard TJ. Postpartum adiponectin concentration, insulin resistance and metabolic abnormalities among women with pregnancy-induced disturbances. Prev Cardiol 2008; 11(2): 106-115.
37. Kirwan JP, Hauguel-De Mouzon S, Lepercq J, et al. TNF-α is a predictor of insulin resistance in human pregnancy. Diabetes 2002; 51: 2207-2213.